Literature DB >> 8257173

Remission death in acute lymphoblastic leukaemia: a changing pattern.

A Atra1, S M Richards, J M Chessells.   

Abstract

The pattern of remission deaths was examined in 842 children with acute lymphoblastic leukaemia (ALL) treated at a single centre over 18 years. The mortality rate from leukaemia fell significantly during three consecutive time periods during which treatment became progressively more intensive and that during remission induction fell from 3.5% to under 1%, but the rate of death in remission stayed constant at 5-6%. The factors associated with an increased risk of remission death were: young age, a higher leucocyte count, bone marrow transplantation, and Down's syndrome. The pattern of remission deaths changed over the years; measles and herpes viruses decreased while deaths associated with periods of intensification and gut toxicity increased. Four children developed second neoplasms. Treatment of ALL is still associated with a significant risk of death in remission but the pattern of infective deaths has changed. Many should be avoidable by provision of adequate supportive care, close supervision after periods of intensive treatment, and appropriate antibiotic, antifungal, and cytokine therapy.

Entities:  

Mesh:

Year:  1993        PMID: 8257173      PMCID: PMC1029616          DOI: 10.1136/adc.69.5.550

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


  19 in total

1.  Improved survival of infants less than 1 year of age with acute lymphoblastic leukemia treated with intensive multiagent chemotherapy.

Authors:  G H Reaman; P G Steinherz; P S Gaynon; W A Bleyer; J Z Finklestein; R Evans; D R Miller; H N Sather; G D Hammond
Journal:  Cancer Treat Rep       Date:  1987-11

2.  Prognosis of Down's syndrome with acute leukaemia.

Authors:  G A Levitt; C A Stiller; J M Chessells
Journal:  Arch Dis Child       Date:  1990-02       Impact factor: 3.791

3.  T cell function in children with acute lymphoblastic leukaemia.

Authors:  K A Nash; G Mohammed; N Nandapalan; J Kernahan; R Scott; A W Craft; G L Toms
Journal:  Br J Haematol       Date:  1993-03       Impact factor: 6.998

4.  Hepatic candidiasis: an increasing problem in immunocompromised patients.

Authors:  E Haron; R Feld; P Tuffnell; B Patterson; R Hasselback; A Matlow
Journal:  Am J Med       Date:  1987-07       Impact factor: 4.965

5.  Immunosuppression and serious infections in children with acute lymphoblastic leukaemia: a comparison of three chemotherapy regimes.

Authors:  N T Rapson; M A Cornbleet; J M Chessells; A J Bennett; R M Hardisty
Journal:  Br J Haematol       Date:  1980-05       Impact factor: 6.998

6.  Intensive consolidation chemotherapy for acute lymphoblastic leukaemia (UKALL X pilot study).

Authors:  C R Pinkerton; A Bowman; H Holtzel; J M Chessells
Journal:  Arch Dis Child       Date:  1987-01       Impact factor: 3.791

7.  Oral methotrexate is as effective as intramuscular in maintenance therapy of acute lymphoblastic leukaemia.

Authors:  J M Chessells; A D Leiper; K Tiedemann; R M Hardisty; S Richards
Journal:  Arch Dis Child       Date:  1987-02       Impact factor: 3.791

8.  Serious infections during continuing treatment of acute lymphoblastic leukaemia.

Authors:  J Ninane; J M Chessells
Journal:  Arch Dis Child       Date:  1981-11       Impact factor: 3.791

9.  Adjuvant low dose radiation in childhood T cell leukaemia/lymphoma (report from the United Kingdom Childrens' Cancer Study Group--UKCCSG).

Authors:  M G Mott; J M Chessells; M L Willoughby; J R Mann; P H Morris-Jones; J S Malpas; M K Palmer
Journal:  Br J Cancer       Date:  1984-10       Impact factor: 7.640

10.  Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. analysis and examples.

Authors:  R Peto; M C Pike; P Armitage; N E Breslow; D R Cox; S V Howard; N Mantel; K McPherson; J Peto; P G Smith
Journal:  Br J Cancer       Date:  1977-01       Impact factor: 7.640

View more
  2 in total

1.  Maintenance treatment and shared care in lymphoblastic leukaemia.

Authors:  J M Chessells
Journal:  Arch Dis Child       Date:  1995-10       Impact factor: 3.791

2.  Treatment related deaths during induction and in first remission in acute lymphoblastic leukaemia: MRC UKALL X.

Authors:  K Wheeler; J M Chessells; C C Bailey; S M Richards
Journal:  Arch Dis Child       Date:  1996-02       Impact factor: 3.791

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.